Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 10 relevant journals 15 Conferences , 48 workshops 29 open access articles are presently dedicated exclusively to Blood Transfusion and about 73 papers are being published on it .
Blood volume is the volume of blood (both RBC and plasma) in the circulatory system of any individual. A typical adult has a blood volume of approximately between 4.7 and 5 litres, with females normally having less blood volume than males. Blood volume is regulated by the kidneys. Blood volume (BV) can be calculated given the hematocrit (HC; the fraction of blood that is red blood cells) and plasma volume (PV). Blood volume measurement is indicated for the diagnosis and treatment patients suffering from Congestive Heart Failure, Chronic hypertension, Renal Failure and Critical Care. Diagnostic technologies are commercially accessible to measure human blood volume. Blood Volume Examination is the only FDA approved instrument that provides a measure of Red Blood Cells and Plasma with 98% accuracy.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope & Importance
Hematology is a distinct subspecialty of internal medicine, separate from but overlapping with the subspecialty of medical oncology. Blood Volume Examination is the only FDA approved instrument that provides a measure Red Blood Cells and Plasma with 98% accuracy. Blood volume measurement is indicated for the diagnosis and treatment patients suffering from Congestive Heart Failure, Chronic hypertension, Renal Failure and Critical Care. With the swift changes and advancement in biomedical/healthcare technology, the healthcare/pharmaceutical/therapeutic industry is becoming ever more competitive. Also, increasing incidences of health related issues owing to changing lifestyles is augmenting the blood plasma industry’s growth. In order to address the rising medical needs related to blood disorders such as autoimmune diseases and liver function impairment among others, Blood Volume conferences are coming up with novel and improved treatment options like IVIG, albumin, clotting factors etc. which are derived from human blood plasma.
According to the report published by Transparency Market Research,the global RFID Blood Monitoring Systems Market was valued at USD 40.9 million in 2012 and is expected to grow at a CAGR of 22.8% from 2013 to 2019, to reach an estimated value of USD 174.2 million in 2019. The global patient monitoring devices market is estimated to reach $22.174 billion by 2018 at a CAGR of 5.5% during the forecast period (2013–2018). North America commanded the largest share in the patient monitoring devices market in 2013 and is expected to grow from 2013 to 2018, at a CAGR of more than 5.0
List of Related Societies
List of Related Companies
This page will be updated regularly.
This page was last updated on February 18, 2020